MAP1A light chain-2 interacts with GTP-RhoB to control epidermal growth factor (EGF)-dependent EGF receptor signaling
Isabelle Lajoie-Mazenc1, Daniel Tovar, Marie Penary
1INSERM U563, Département Oncogénèse, Signalisation et Innovation Thérapeutique, Toulouse F-31059, France. lajoie.isabelle@claudiusregaud.fr
Abstract:
Rho GTPases have been implicated in the control of several cellular functions, including regulation of the actin cytoskeleton, cell proliferation, and oncogenesis. Unlike RhoA and RhoC, RhoB localizes in part to endosomes and controls endocytic trafficking. Using a yeast two-hybrid screen and a glutathione S-transferase pulldown assay, we identified LC2, the light chain of the microtubule-associated protein MAP1A, as a novel binding partner for RhoB. GTP binding and the 18-amino acid C-terminal hypervariable domain of RhoB are critical for its binding to MAP1A/LC2. Coimmunoprecipitation and immunofluorescence experiments showed that this interaction occurs in U87 cells. Down-regulation of MAP1A/LC2 expression decreased epidermal growth factor (EGF) receptor expression and modified the signaling response to EGF treatment. We concluded that MAP1A/LC2 is critical for RhoB function in EGF-induced EGF receptor regulation. Because MAP1A/LC2 is thought to function as an adaptor between microtubules and other molecules, we postulate that the RhoB and MAP1A/LC2 interactions facilitate endocytic vesicle trafficking and regulate the trafficking of signaling molecules.
Insights
RhoB GTPase interacts with MAP1A/LC2, crucial for regulating epidermal growth factor (EGF) receptor trafficking and signaling. This discovery highlights a new role for RhoB in endocytic pathways.
Area of Science:
- Cell Biology
- Molecular Biology
- Signal Transduction
Background:
- Rho GTPases regulate diverse cellular processes, including cytoskeleton dynamics and oncogenesis.
- RhoB specifically localizes to endosomes, influencing endocytic trafficking.
- Microtubule-associated protein 1A light chain 2 (MAP1A/LC2) is involved in microtubule organization.
Purpose of the Study:
- To identify novel binding partners of RhoB.
- To elucidate the role of RhoB-MAP1A/LC2 interaction in cellular signaling.
- To investigate the function of RhoB in regulating epidermal growth factor (EGF) receptor.
Main Methods:
- Yeast two-hybrid screening to identify RhoB interacting proteins.
- Glutathione S-transferase pulldown assays to confirm binding.
- Coimmunoprecipitation and immunofluorescence in U87 cells to validate interaction.
- Gene silencing to assess the functional impact of MAP1A/LC2 down-regulation.
Main Results:
- LC2, the light chain of MAP1A, was identified as a novel binding partner for RhoB.
- GTP binding and the C-terminal hypervariable domain of RhoB are essential for MAP1A/LC2 interaction.
- MAP1A/LC2 down-regulation reduced EGF receptor expression and altered EGF signaling.
- The RhoB-MAP1A/LC2 interaction was confirmed in U87 human glioblastoma cells.
Conclusions:
- MAP1A/LC2 is critical for RhoB-mediated regulation of EGF receptor expression and signaling.
- The RhoB-MAP1A/LC2 complex likely facilitates endocytic vesicle trafficking.
- This interaction may regulate the trafficking of signaling molecules, impacting cellular responses to growth factors.
More Related Videos
Related Concept Videos
Small GTPases - Ras and Rho
Three regulatory proteins control their activity:
Mitogens and the Cell Cycle
MAPK Signaling Cascades
TGF - β Signaling Pathway
Activation and Inactivation of G Proteins
Receptor Tyrosine Kinases


